Controversies in Diagnosis and Management of Atrial Fibrillation

Tanvi Nayak1, Graham Lohrmann2, Rod Passman2,3,4

  • 1From the Feinberg School of Medicine, Northwestern University, Chicago, IL.

Cardiology in Review
|July 29, 2024
PubMed

Insights

Early detection of atrial fibrillation (AF) is crucial for preventing cardiovascular events. New wearable devices enable detection of asymptomatic AF, prompting research into screening effectiveness and stroke prevention strategies.

Area of Science:

  • Cardiology
  • Digital Health
  • Preventive Medicine

Background:

  • Early detection of atrial fibrillation (AF) is vital for reducing adverse cardiovascular outcomes.
  • A significant portion of AF cases are asymptomatic, leading to delayed diagnosis and treatment.
  • Traditional AF diagnosis relied on electrocardiograms and external monitors, limiting detection of subclinical events.

Purpose of the Study:

  • To review recent advancements in AF detection technologies, including wearable devices.
  • To discuss the implications of subclinical AF on stroke risk and anticoagulation therapy.
  • To explore emerging strategies for AF screening, rhythm maintenance, and stroke prevention.

Main Methods:

  • Review of recent scientific literature and clinical studies on AF detection and management.
  • Analysis of data from cardiovascular implantable electronic devices and consumer-grade wearables.
  • Examination of research on catheter ablation and left atrial appendage occlusion.

Main Results:

  • Device-monitoring technologies have increased the recognition of subclinical AF.
  • Studies are providing insights into stroke risks associated with subclinical AF and anticoagulation efficacy.
  • Emerging research focuses on novel interventions for sinus rhythm maintenance and stroke prevention.

Conclusions:

  • Subclinical AF detection via new technologies raises questions about optimal screening strategies.
  • Further research is needed to refine the use of medical and direct-to-consumer AF detection devices.
  • Advancements in catheter ablation and left atrial appendage occlusion offer new avenues for stroke prevention in AF patients.

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
927
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
727
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
812
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
667